A comprehensive pan-cancer study identifies the ribosome biogenesis enzyme DIMT1 as a prognostic and immune-associated ...

A new commentary in BMC Cancer warns that pan-cancer studies treating CFH as a single cancer biomarker have been measuring an ...

RNA fusions offer new drug targets and insights into disease mechanisms, but detecting them is difficult. Workflows that integrate different types of samples and analyses can help.

Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause of mortality worldwide, highlighting the urgent need for continued research to identify ...

Researchers found that very small elevations in two biomarkers are strong and independent predictors of overall cancer risk, with a higher incidence in specific types of cancer. Two specific ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

PITTSBURGH, June 12, 2026 /PRNewswire/ -- Allegheny Health Network (AHN) Cancer Institute today announced that its Biomarker Moonshot Cancer Research Program has surpassed 11,000 enrolled patients, ...